Filter posts

Europe Turns its Back on Science

On October 24th, The New York Times published a great opinion piece titled “With G.M.O. …

EU States Opt-Out of Innovation

A number of international media outlets are reporting on EU member states choosing to opt-out …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated …

EU Stem Cell Patent Decision Hurts Science

A great article in the Economist titled European science stemmed addresses the recent and controversial decision …

Biotechnology Patenting in Europe Event

BIO hosted a Biotechnology Patenting in Europe event last week here at BIO’s offices where …

The Truth About Biotech Crops

There have been some misconceptions floating around in the internet with regard to biotech crop …